The Procter & Gamble Company (NYSE:PG) Shares Sold by Sigma Planning Corp

Sigma Planning Corp lowered its stake in The Procter & Gamble Company (NYSE:PG) by 3.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 69,373 shares of the company’s stock after selling 2,317 shares during the quarter. Sigma Planning Corp’s holdings in Procter & Gamble were worth $12,015,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of PG. Itau Unibanco Holding S.A. acquired a new stake in shares of Procter & Gamble during the second quarter valued at about $28,000. Fairway Wealth LLC purchased a new position in Procter & Gamble in the second quarter valued at about $29,000. POM Investment Strategies LLC acquired a new stake in Procter & Gamble during the 2nd quarter valued at approximately $34,000. Quest Partners LLC purchased a new stake in Procter & Gamble during the 2nd quarter worth approximately $36,000. Finally, Fairfield Financial Advisors LTD acquired a new position in shares of Procter & Gamble in the 2nd quarter valued at approximately $44,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the transaction, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In related news, CEO Ma. Fatima Francisco sold 96,000 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $170.00, for a total value of $16,320,000.00. Following the sale, the chief executive officer now directly owns 13,721 shares in the company, valued at $2,332,570. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the sale, the chief financial officer now owns 37,208 shares of the company’s stock, valued at $6,325,360. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 313,597 shares of company stock valued at $53,268,499. Company insiders own 0.18% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the stock. DA Davidson lifted their price target on shares of Procter & Gamble from $159.00 to $160.00 and gave the stock a “neutral” rating in a research note on Monday, October 21st. DZ Bank raised shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price for the company in a research report on Thursday, August 29th. Piper Sandler began coverage on shares of Procter & Gamble in a research report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price target on the stock. JPMorgan Chase & Co. lifted their price target on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research note on Thursday, September 19th. Finally, Morgan Stanley upped their price objective on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Nine research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $177.00.

Procter & Gamble Stock Performance

Shares of NYSE PG opened at $167.71 on Friday. The Procter & Gamble Company has a 12-month low of $142.50 and a 12-month high of $177.94. The company has a market cap of $394.96 billion, a PE ratio of 28.92, a P/E/G ratio of 3.48 and a beta of 0.42. The stock has a 50 day simple moving average of $171.08 and a 200-day simple moving average of $168.15. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The company had revenue of $21.74 billion during the quarter, compared to analyst estimates of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm’s quarterly revenue was down .6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.83 EPS. On average, equities research analysts forecast that The Procter & Gamble Company will post 6.94 EPS for the current year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a dividend of $1.0065 per share. The ex-dividend date is Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.40%. Procter & Gamble’s payout ratio is 69.31%.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.